3 unknown, 1 not yet recruiting. 4 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Unknown 3, Not yet recruiting 1 |
| Phase 2 | 2 | Unknown 2 |
Follow Letolab: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Clinical Study of LTC004 in Patients With Advanced Sarcoma LTC004 - Unresectable or Metastatic Sarcoma | Phase 1 / Phase 2 | Unknown | Letolab | 30 | 2024-04-26 | 2024-04-25 |
| Phase II Clinical Study of LTC004 in Patients With mCRC LTC004 - Locally Advanced or Metastatic CRC | Phase 1 / Phase 2 | Unknown | Letolab | 30 | 2024-04-25 | 2024-04-25 |
| A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor LTC004 in Combination With Cyclophosphamide and Fludarabine - Adult Solid Tumor | Phase 1 | Not yet recruiting | Letolab | 48 | 2024-03-01 | 2024-02-26 |
| Study of LTC004 in Subjects With Advanced Malignant Tumors LTC004 - Adult Solid Tumor | Phase 1 | Unknown | Letolab | 368 | 2022-12-01 | 2022-12-28 |
Sarcoma (1)
Cyclophosphamide (1) · fludarabine (1)